Clinical Trial

Investigation on Risk Factors for Suicide Among Chinese Patients With Mood Disorders

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 15, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Main research objective: Through questionnaire surveys, obtain the occurrence levels of self-harm/suicide behaviors, the status of acquired suicidal ability, and their correlations with self-harm/suicide behaviors among patients with mood disorders in mental specialty hospitals and general hospitals. Main research purpose: (1) Conduct a comprehensive assessment and analysis of the occurrence of suicide/self-harm behaviors, the level of acquired suicidal ability, and their distribution among patients with mood disorders in China; (2) Compare the characteristics and acquired suicidal ability status of patients with mood disorders in mental specialty hospitals and general hospitals' psychological outpatient departments regarding suicide/self-harm behaviors; (3) From multiple dimensions, explore the influencing factors of self-harm/suicide behaviors and acquired suicidal ability in patients with mood disorders, form a list of suicide risk factors and clarify the key risk factors, establish a predictive model for acquired suicidal ability; (4) Through follow-up on whether patients have another occurrence of suicide behavior, clarify the impact of key risk factors on the occurrence of suicide behavior, and verify the effectiveness of the predictive model for acquired suicidal ability.
Trial Details
NCT Number NCT07281729
Lead Sponsor Shanghai Mental Health Center
Conditions Bipolar Disorder;Major Depressive Disorder;Mood Disorders
Enrollment 25,000 participants
Start Date 2025-08-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-15